News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Match Group bakes Tinder recovery and Hinge growth into guidance, supporting further upside for MTCH despite the recent rally.
  • PTC appears undervalued with strong free cash flow and mid-teens multiple re-rating potential from AI and digital twin expansion.
  • Teladoc offers cheap cash-flow metrics and an outcomes-based integrated care product that could drive higher-margin revenue.
  • Marvell is positioned as a leveraged AI infrastructure play via data-center exposure and Nvidia ties, supporting a long-trade thesis.
  • Viavi's revenue and profit acceleration with bullish guidance sets up a mid-term swing trade tied to optical networking demand.

Latest Articles

FingerMotion Announces Leadership Change

FingerMotion Announces Leadership Change

FingerMotion, Inc., a Nasdaq-listed mobile services and technology company, announced a leadership change with the appointment of Jolie Kahn as CEO, succeeding Martin Shen. Kahn brings extensive experience in corporate finance, public company management, and digital asset-related businesses. The company aims to leverage its growing user base and in…

XFLT Urges Shareholders to Approve the King Street Sub-Adviser and Effect Liquidity Plan Ahead of August 6th Meeting

XFLT Urges Shareholders to Approve the King Street Sub-Adviser and Effect Liquidity Plan Ahead of August 6th Meeting

XAI Floating Rate & Alternative Income Trust (XFLT) is urging shareholders to vote in favor of appointing King Street Capital Management's subsidiary as long-term sub-adviser and approve a liquidity plan involving tender offers to repurchase 25% of fund shares. Key proxy advisory firms and investment research services recommend voting for the propo…

TSX Futures Rise as Iran Peace Prospects and Shopify Forecast Lift Sentiment

TSX Futures Rise as Iran Peace Prospects and Shopify Forecast Lift Sentiment

Futures tied to Canada’s primary stock benchmark were trading higher as market participants reacted to signs of progress toward a potential US-Iran agreement and parsed quarterly results and guidance from Shopify. The S&P/TSX 60 futures climbed materially, aided by strength in technology and metal mining names. Simultaneously, developments in oil a…

SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome

SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome

SciSparc Ltd., through its subsidiary NeuroThera Labs, has launched a Phase IIb clinical trial of SCI-110, a cannabinoid-based drug candidate for Tourette Syndrome treatment, at Yale Child Study Center in the USA. This multinational trial also includes sites in Germany and Israel and builds on positive Phase IIa results, aiming to advance regulator…

Ocean Power Technologies Selected for Participation in $40 Million U.S. Navy Project for Autonomous Ocean Mapping

Ocean Power Technologies Selected for Participation in $40 Million U.S. Navy Project for Autonomous Ocean Mapping

Ocean Power Technologies, Inc. (NYSE American: OPTT) has been chosen as one of six potential awardees for a $40 million multiple-award contract by the U.S. Naval Oceanographic Office to provide high-resolution ocean-floor mapping using long-endurance unmanned surface vehicles. The contract spans two years with task orders competed among awardees an…

Senior Source Says No Talks Underway Between AstraZeneca and Bristol Myers

Senior Source Says No Talks Underway Between AstraZeneca and Bristol Myers

A senior source close to the situation said there are no ongoing discussions between AstraZeneca and Bristol Myers Squibb about a merger. The source, speaking on condition of anonymity, stated that there never was a deal to be done. Earlier reports had suggested preliminary talks that could have created a combined pharmaceutical entity valued near …

Alpha Modus Targets Approximately $8 Million in Revenue Under Multi-Year National Consumer Market Research Services Agreement

Alpha Modus Targets Approximately $8 Million in Revenue Under Multi-Year National Consumer Market Research Services Agreement

Alpha Modus Holdings, an AI technology company specializing in consumer engagement and data analytics, announced a multi-year services agreement with a national market research firm expected to generate approximately $8 million in revenue over multiple years. This contract marks the company's entry into a new enterprise services vertical beyond its…

Analyst Says Share-Count Surge and Big Capex Drive SpaceX Premarket Drop

Analyst Says Share-Count Surge and Big Capex Drive SpaceX Premarket Drop

SpaceX shares fell more than 11% in premarket trading even after a quarter that outperformed expectations. Piper Sandler told clients the market reaction reflects an expected sharp increase in tradable shares, a materially higher fiscal 2027 capital expenditure plan and the uncertain longevity of lucrative but cancelable AI cloud contracts, rather …

BorgWarner Shares Leap After Strong Q2, Higher Guidance and Bigger Buyback

BorgWarner Shares Leap After Strong Q2, Higher Guidance and Bigger Buyback

BorgWarner's stock jumped 7.0% in pre-market trading after the automotive supplier reported a notable second-quarter earnings beat, lifted its full-year 2026 guidance, and expanded its share repurchase authorization by $1 billion. The quarter featured higher adjusted operating margin and revenues that surpassed analyst estimates, while management s…

SolarEdge Shares Drop Sharply After Q2 Results, Q3 Outlook Disappoints

SolarEdge Shares Drop Sharply After Q2 Results, Q3 Outlook Disappoints

SolarEdge Technologies stock slumped in pre-market trading after the company reported Q2 2026 results that beat consensus on both EPS and revenue but issued Q3 2026 revenue guidance below analysts' projections. The guidance shortfall, combined with a reversal of prior-session policy-driven gains and lingering concerns about U.S. residential solar d…